Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells

Molecular Cancer Research

Volumn 1, Issue 10, 2003, Pages 739-746

  Ma, Hongwen ^a   Urquidi, Virginia ^b   Wong, Jeremy ^a   Kleeman, Jeanine ^a   Goodison, Steve ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIN; ONCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL DIFFERENTIATION; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; MUSCLE CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RHABDOMYOSARCOMA; SARCOMA CELL; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BINDING SITES; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA-BINDING PROTEINS; E-BOX ELEMENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MUSCLE CELLS; MUTAGENESIS, SITE-DIRECTED; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MYC; RHABDOMYOSARCOMA; TELOMERASE; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 0041426742     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., and Lansdorp, P. M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. USA, 91: 9857-9860, 1994.
2. Autexier, C., Pruzan, R., Funk, W. D., and Greider, C. W. Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA. EMBO J., 15: 5928-5935, 1996.
3. Urquidi, V., Tarin, D., and Goodison, S. Role of telomerase in cell senescence and oncogenesis. Annu. Rev. Med., 51: 65-79, 2000.
4. Sugino, T., Yoshida, K., Bolodeoku, J., Tarin, D., and Goodison, S. Telomerase activity and its inhibition in benign and malignant breast lesions. J. Pathol., 183: 57-61, 1997.
5. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. Telomerase catalytic subunit homologues from fission yeast and human. Science, 277: 955-959, 1997.
6. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddlc, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90: 785-795, 1997.
7. Vaziri, H. and Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol., 8: 279-282, 1998.
8. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. Extension of life span by introduction of telomerase into normal human cells. Science, 279: 349-352, 1998.
9. Ulaner, G. A. and Giudice, L. C. Developmental regulation of telomerase activity in human fetal tissues during gestation. Mol. Hum. Reprod., 3: 769-773, 1997.
10. Ulaner, G. A., Hu, J. F., Vu, T. H., Giudice, L. C., and Hoffman, A. R. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res., 58: 4168-4172, 1998.
11. Pendino, F., Flexor, M., Delhommeau, F., Buet, D., Lanotte, M., and Segal-Bendirdjian, E. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc. Natl. Acad. Sci. USA, 98: 6662-6667, 2001.
12. Xu, D., Gruber, A., Bjorkholm, M., Petersori, C., and Pisa, P. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br. J. Cancer, 80: 1156-1161, 1999.
13. Xu, D., Popov, N., Hou, M., Wang, Q., Bjorkholm, M., Gruber, A., Menkel, A. R., and Henriksson, M., Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the telomerase reverse transcriptase promoter during differentiation of HL60 cells. Proc. Natl. Acad. Sci. USA. 98: 3826-3831, 2001.
14. Nozawa, K., Maehara, K., and Isobe, K. Mechanism for the reduction of telomerase expression during muscle cell differentiation. J. Biol. Chem., 276: 22016-22023, 2001.
15. Gewin, L. and Galloway, D. A. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol., 75: 7198-7201, 2001.
16. Aguanno, S., Bouche, M., Adamo, S., and Molinaro, M. 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of a human rhabdomyosarcoma cell line. Cancer Res., 50: 3377-3382, 1990.
17. Bouche, M., Zappelli, F., Polimeni, M., Adamo, S., Wetsel, W. C., Senni, M. I., and Molinaro, M. Rapid activation and down-regulation of protein kinase C α in 12-O-tetradecanoylphorbol-13-acetate-induced differentiation of human rhabdomyosarcoma cells. Cell Growth Differ., 6: 845-852, 1995.
18. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science, 266: 2011-2015, 1994.
19. Molkentin, J. D., Black, B. L., Martin, J. F., and Olson, E. N. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell, 83: 1125-1136, 1995.
20. Cong, Y. S., Wen, J., and Bacchetti, S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet., 8: 137-142, 1999.
21. Horikawa, I., Cable, P. L., Afshari, C., and Barrett, J. C. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res., 59: 826-830, 1999.
22. Ayer, D. E., Kretzner, L., and Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell, 72: 211-222, 1993.
23. Wolffe, A. P. Transcriptional control. Sinful repression. Nature. 387: 16-17, 1997.
24. Cong, Y. S. and Bacchetti, S. Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J. Biol. Chem., 275: 35665-35668, 2000.
25. McPherson, L. A. and Weigel, R. J. AP2α and AP2γ: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs. Nucleic Acids Res., 27: 4040-4049, 1999.
26. Drissi, R., Zindy, F., Roussel, M. F., and Cleveland, J. L. c-Myc mediated regulation of telomerase activity is disabled in immortalized cells. J. Biol. Chem., 11: 11, 2001.
27. Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., and Inoue, M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res., 59: 551-557, 1999.
28. Dang, C. V., Resar, L. M., Emison, E., Kim, S., Li, Q., Prescott, J. E., Wonsey, D., and Zeller, K. Function of the c-MyC oncogenic transcription factor. Exp. Cell Res., 253: 63-77, 1999.
29. Batsche, E., Muchardt, C., Behrens, J., Hurst, H. C., and Cremisi, C. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol. Cell. Biol., 18: 3647-3658, 1998.
30. Gaubatz, S., Imhof, A., Dosch, R., Werner, O., Mitchell, P., Buettner, R., and Eilers, M. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J., 14: 1508-1519, 1995.
31. Bestilny, L. J., Brown, C. B., Miura, Y., Robertson, L. D., and Riabowol, K. T. Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res., 56: 3796-3802, 1996.
32. Holt, S. E., Wright, W. E., and Shay, J. W. Regulation of telomerase activity in immortal cell lines. Mol. Cell. Biol., 16: 2932-2939, 1996.
33. Vinals, F., Fandos, C., Santalucia, T., Ferre, J., Testar, X., Palacin, M., and Zorzano, A. Myogenesis and MyoD down-regulate Sp1. A mechanism for the repression of GLUT1 during muscle cell differentiation. J. Biol. Chem., 272: 12913-12921, 1997.
34. Yago, M., Ohki, R., Hatakeyama, S., Fujita, T., and Ishikawa, F., Variant forms of upstream stimulatory factors (USFS) control the promoter activity of hTERT,the human gene encoding the catalytic subunit of telomerase. FEBS Lett., 520: 40-46, 2002.
35. Kiermaier, A., Gawn, J. M., Desbarats, L., Saffrich, R., Ansorge, W., Farrell, P. J., Eilers, M., and Packham, G. DNA binding of USF is required for specific E-box dependent gene activation in vivo. Oncogene, 18: 7200-7211, 1999.
36. Qyang, Y., Luo, X., Lu, T., Ismail, P. M., Krylov, D., Vinson, C., and Sawadogo M. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol. Cell. Biol., 19: 1508-1517, 1999.
37. Luo, X. and Sawadogo, M. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc. Natl. Acad. Sci. USA, 93: 1308-1313, 1996.
38. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H., and Inoue, M. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res., 28: 669-677, 2000.
39. Aogi, K., Woodman, A., Urquidi, V., Mangham, D. C., Tarin, D., and Goodison, S. Telomerase activity in soft-tissue and bone sarcomas. Clin. Cancer Res., 6: 4776-4781, 2000.